Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone and BBTI for Complex Insomnia in Veterans
NCT03937713Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eszopiclone in Insomnia (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Pittsburgh Sleep Quality Index at 6 months. Started Dec 2019; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03937713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937713.